Home / AKUMS.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AKUMS.NS make money? Does AKUMS.NS have pricing power? What's the Earnings Whisper? Will AKUMS.NS profit more as the business scales? What is AKUMS.NS's management track record? Is AKUMS.NS's current price justified?

Akums Drugs & Pharmaceuticals Ltd.

₹731 +$284.50 (+63.72%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹749.8

Day Range

₹728.7₹752.8

Year Range

₹409.3₹838.8

Market Cap

111.92B

AVG Volume

359.87K

Trailing/Forward PE

38.37/21.4

PEG ratio

0.65

Dividend Yield

0.41%

Next Earnings Date

2026-11-12

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

AKUMS.NS Revenue (INR) by quarter
Period	Revenue (INR)
26 Q1	11.67B
25 Q4	11.58B
25 Q3	11.6B
25 Q2	10.18B
25 Q1	10.24B
24 Q4	10.08B
24 Q3	10.1B
24 Q2	10.33B

Net Income (INR) · Q

AKUMS.NS Net Income (INR) by quarter
Period	Net Income (INR)
26 Q1	1B
25 Q4	846.13M
25 Q3	663.17M
25 Q2	407.83M
25 Q1	634.75M
24 Q4	1.48B
24 Q3	651.82M
24 Q2	652.06M

Operating Income (INR) · Q

AKUMS.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
26 Q1	1.34B
25 Q4	1.12B
25 Q3	1.07B
25 Q2	566.12M
25 Q1	920.5M
24 Q4	574M
24 Q3	768.45M
24 Q2	863.2M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Akums Drugs & Pharmaceuticals Ltd.

Video analysis: AKUMS.NS

News: AKUMS.NS

Similar companies